Autopsy report · NCT04442126

A Study of NM21-1480 in Adult Patients With Advanced Solid Tumors

“A business decision was made to discontinue further enrollment. There were no safety concerns that contributed to this decision.”

The sponsor’s own words in the registry.

Life of this trial

• Registered 2 months before it started.
• Ran for about 3 years 6 months before it stopped.
• 52 participants enrolled.
• Results were posted on the registry 1 year 4 months after it ended.

Vital statistics

Status

Terminated

Phase

Phase 1, Phase 2

Sponsor

Numab Therapeutics AG

Sponsor type

Industry

Conditions

Advanced Solid Tumor; Non-small Cell Lung Cancer; Colorectal Cancer; Squamous Cell Carcinoma; Ovarian Carcinoma; Peritoneal Carcinoma

Interventions

NM21-1480

Participants

52

Sites

26

Countries

Spain, Taiwan, United States

Trials that died the same way

• EnligHTN IV Trial - Multicenter Sham-controlled RCT of Renal Denervation for Hypertension
  “There were no safety or effectiveness concerns. There were concerns about completing enrollment due to a competitive device's potential approval.” (81% match in meaning)
• A Study of TAK-659 in Combination With Bendamustine (+/-Rituximab), Gemcitabine, Lenalidomide, or Ibrutinib for the Treatment of Participants With Advanced Non-Hodgkin Lymphoma
  “Business decision, insufficient enrollment, no safety or efficacy concerns.” (81% match in meaning)
• A Study to Evaluate INCB177054 in Participants With Select Advanced or Metastatic Solid Tumors
  “This was a strategic business decision. There were no safety concerns contributing to this decision.” (77% match in meaning)
• A Safety Study of IV Stem Cell-derived Extracellular Vesicles (UNEX-42) in Preterm Neonates at High Risk for BPD
  “The study was discontinued due to a business decision; no safety concerns were noted.” (74% match in meaning)
• Dual-Orexin Antagonism As a Mechanism for Improving Sleep and Drug Abstinence in Opioid Use Disorder
  “Did not meet enrollment goals.” (70% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.